Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
TCMD's Cash-to-Debt is ranked higher than
79% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. TCMD: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
TCMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 297.23  Med: No Debt Max: No Debt
Current: No Debt
297.23
No Debt
Equity-to-Asset 0.82
TCMD's Equity-to-Asset is ranked higher than
79% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. TCMD: 0.82 )
Ranked among companies with meaningful Equity-to-Asset only.
TCMD' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.2  Med: 0.82 Max: 0.85
Current: 0.82
-0.2
0.85
Interest Coverage No Debt
TCMD's Interest Coverage is ranked higher than
77% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 66.37 vs. TCMD: No Debt )
Ranked among companies with meaningful Interest Coverage only.
TCMD' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 33.00
Beneish M-Score: -2.33
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 4.37
TCMD's Operating Margin % is ranked higher than
54% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. TCMD: 4.37 )
Ranked among companies with meaningful Operating Margin % only.
TCMD' s Operating Margin % Range Over the Past 10 Years
Min: 3.57  Med: 5.49 Max: 7.96
Current: 4.37
3.57
7.96
Net Margin % 4.92
TCMD's Net Margin % is ranked higher than
62% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. TCMD: 4.92 )
Ranked among companies with meaningful Net Margin % only.
TCMD' s Net Margin % Range Over the Past 10 Years
Min: 2.22  Med: 4.34 Max: 8.49
Current: 4.92
2.22
8.49
ROE % 8.63
TCMD's ROE % is ranked higher than
68% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. TCMD: 8.63 )
Ranked among companies with meaningful ROE % only.
TCMD' s ROE % Range Over the Past 10 Years
Min: 6.05  Med: 7.45 Max: 8.84
Current: 8.63
6.05
8.84
ROA % 7.17
TCMD's ROA % is ranked higher than
80% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. TCMD: 7.17 )
Ranked among companies with meaningful ROA % only.
TCMD' s ROA % Range Over the Past 10 Years
Min: 4.07  Med: 6.82 Max: 10.8
Current: 7.17
4.07
10.8
ROC (Joel Greenblatt) % 26.99
TCMD's ROC (Joel Greenblatt) % is ranked higher than
72% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. TCMD: 26.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
TCMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.82  Med: 25.64 Max: 34.94
Current: 26.99
19.82
34.94
3-Year Revenue Growth Rate 17.40
TCMD's 3-Year Revenue Growth Rate is ranked lower than
99.99% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. TCMD: 17.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
TCMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 17.4  Med: 29.35 Max: 41.3
Current: 17.4
17.4
41.3
3-Year EBITDA Growth Rate -3.40
TCMD's 3-Year EBITDA Growth Rate is ranked lower than
99.99% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. TCMD: -3.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
TCMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.4  Med: 12.55 Max: 28.5
Current: -3.4
-3.4
28.5
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» TCMD's 30-Y Financials

Financials (Next Earnings Date: 2019-02-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2017

TCMD Guru Trades in Q4 2017

Chuck Royce 105,489 sh (+0.05%)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q1 2018

TCMD Guru Trades in Q1 2018

Chuck Royce 107,269 sh (+1.69%)
» More
Q2 2018

TCMD Guru Trades in Q2 2018

Chuck Royce 71,682 sh (-33.18%)
» More
Q3 2018

TCMD Guru Trades in Q3 2018

Chuck Royce 40,824 sh (-43.05%)
» More
» Details

Insider Trades

Latest Guru Trades with TCMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:SZSE:300562, NYSE:IVC, SZSE:300314, HKSE:01789, XKRX:043150, ROCO:8406, XBRU:IBAB, SZSE:300206, NAS:VRAY, SZSE:300318, NAS:ARAY, SZSE:300216, NAS:EXAC, NYSE:CRY, NAS:CUTR, NAS:CSII, NAS:MDXG, OSTO:ARJO B, XKRX:085370, XKRX:099190 » details
Traded in other countries:3L3.Germany,
Headquarter Location:USA
Tactile Systems Technology Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic swelling condition at home. Its products include Flexitouch System, the Entre System, and the ACTitouch System.

Tactile Systems Technology Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic swelling condition at home. Its products include Flexitouch System, the Entre System, and the ACTitouch System.

Ratios

vs
industry
vs
history
PE Ratio 140.78
TCMD's PE Ratio is ranked lower than
91% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. TCMD: 140.78 )
Ranked among companies with meaningful PE Ratio only.
TCMD' s PE Ratio Range Over the Past 10 Years
Min: 6.14  Med: 89.64 Max: 213.47
Current: 140.78
6.14
213.47
Forward PE Ratio 140.85
TCMD's Forward PE Ratio is ranked lower than
98% of the 52 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. TCMD: 140.85 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 140.78
TCMD's PE Ratio without NRI is ranked lower than
91% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. TCMD: 140.78 )
Ranked among companies with meaningful PE Ratio without NRI only.
TCMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 6.14  Med: 89.64 Max: 213.47
Current: 140.78
6.14
213.47
PB Ratio 10.57
TCMD's PB Ratio is ranked lower than
83% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. TCMD: 10.57 )
Ranked among companies with meaningful PB Ratio only.
TCMD' s PB Ratio Range Over the Past 10 Years
Min: 4.18  Med: 7.65 Max: 15.71
Current: 10.57
4.18
15.71
PS Ratio 6.88
TCMD's PS Ratio is ranked lower than
68% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. TCMD: 6.88 )
Ranked among companies with meaningful PS Ratio only.
TCMD' s PS Ratio Range Over the Past 10 Years
Min: 2.68  Med: 5.11 Max: 10.3
Current: 6.88
2.68
10.3
Price-to-Free-Cash-Flow 386.07
TCMD's Price-to-Free-Cash-Flow is ranked lower than
100% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.44 vs. TCMD: 386.07 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
TCMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 34.5  Med: 431.53 Max: 3213
Current: 386.07
34.5
3213
Price-to-Operating-Cash-Flow 120.58
TCMD's Price-to-Operating-Cash-Flow is ranked lower than
96% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 20.01 vs. TCMD: 120.58 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
TCMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 30.85  Med: 136.94 Max: 425.61
Current: 120.58
30.85
425.61
EV-to-EBIT 145.03
TCMD's EV-to-EBIT is ranked lower than
97% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.76 vs. TCMD: 145.03 )
Ranked among companies with meaningful EV-to-EBIT only.
TCMD' s EV-to-EBIT Range Over the Past 10 Years
Min: 39.9  Med: 142.85 Max: 289.5
Current: 145.03
39.9
289.5
EV-to-EBITDA 92.83
TCMD's EV-to-EBITDA is ranked lower than
96% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 18.14 vs. TCMD: 92.83 )
Ranked among companies with meaningful EV-to-EBITDA only.
TCMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 33  Med: 96.9 Max: 193.4
Current: 92.83
33
193.4
EV-to-Revenue 6.34
TCMD's EV-to-Revenue is ranked lower than
61% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 3.73 vs. TCMD: 6.34 )
Ranked among companies with meaningful EV-to-Revenue only.
TCMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.2  Med: 4.85 Max: 10.2
Current: 6.34
2.2
10.2
Current Ratio 5.32
TCMD's Current Ratio is ranked higher than
80% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. TCMD: 5.32 )
Ranked among companies with meaningful Current Ratio only.
TCMD' s Current Ratio Range Over the Past 10 Years
Min: 1.79  Med: 5.13 Max: 6.49
Current: 5.32
1.79
6.49
Quick Ratio 4.43
TCMD's Quick Ratio is ranked higher than
81% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. TCMD: 4.43 )
Ranked among companies with meaningful Quick Ratio only.
TCMD' s Quick Ratio Range Over the Past 10 Years
Min: 1.43  Med: 4.43 Max: 5.17
Current: 4.43
1.43
5.17
Days Inventory 135.95
TCMD's Days Inventory is ranked higher than
64% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 143.61 vs. TCMD: 135.95 )
Ranked among companies with meaningful Days Inventory only.
TCMD' s Days Inventory Range Over the Past 10 Years
Min: 92.35  Med: 100.4 Max: 135.95
Current: 135.95
92.35
135.95
Days Sales Outstanding 55.72
TCMD's Days Sales Outstanding is ranked higher than
67% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 69.21 vs. TCMD: 55.72 )
Ranked among companies with meaningful Days Sales Outstanding only.
TCMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.72  Med: 82.15 Max: 105.07
Current: 55.72
55.72
105.07
Days Payable 39.96
TCMD's Days Payable is ranked lower than
54% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. TCMD: 39.96 )
Ranked among companies with meaningful Days Payable only.
TCMD' s Days Payable Range Over the Past 10 Years
Min: 39.96  Med: 71.97 Max: 73.21
Current: 39.96
39.96
73.21

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -10.20
TCMD's 3-Year Average Share Buyback Ratio is ranked lower than
99.99% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. TCMD: -10.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
TCMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: -9.1 Max: -8
Current: -10.2
-10.2
-8

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 31.91
TCMD's Price-to-Net-Cash is ranked lower than
63% of the 104 Companies
in the Global Medical Devices industry.

( Industry Median: 14.24 vs. TCMD: 31.91 )
Ranked among companies with meaningful Price-to-Net-Cash only.
TCMD' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 10.07  Med: 18.34 Max: 47.37
Current: 31.91
10.07
47.37
Price-to-Net-Current-Asset-Value 12.43
TCMD's Price-to-Net-Current-Asset-Value is ranked lower than
59% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 7.79 vs. TCMD: 12.43 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
TCMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 5.53  Med: 9.1 Max: 18.45
Current: 12.43
5.53
18.45
Price-to-Tangible-Book 10.98
TCMD's Price-to-Tangible-Book is ranked lower than
71% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. TCMD: 10.98 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
TCMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.83  Med: 7.85 Max: 16.28
Current: 10.98
4.83
16.28
Price-to-Median-PS-Value 1.35
TCMD's Price-to-Median-PS-Value is ranked lower than
67% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. TCMD: 1.35 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
TCMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.58  Med: 0.96 Max: 2
Current: 1.35
0.58
2
Price-to-Graham-Number 8.33
TCMD's Price-to-Graham-Number is ranked lower than
88% of the 133 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. TCMD: 8.33 )
Ranked among companies with meaningful Price-to-Graham-Number only.
TCMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.42  Med: 5.06 Max: 12.36
Current: 8.33
1.42
12.36
Earnings Yield (Greenblatt) % 0.69
TCMD's Earnings Yield (Greenblatt) % is ranked higher than
50% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.74 vs. TCMD: 0.69 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
TCMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.3  Med: 0.7 Max: 2.5
Current: 0.69
0.3
2.5

More Statistics

Revenue (TTM) (Mil) $132.19
EPS (TTM) $ 0.34
Volatility61.73%
52-Week Range $27.04 - 73.24
Shares Outstanding (Mil)18.47

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 137 165 195
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.24 0.35 0.49
EPS without NRI ($) 0.24 0.35 0.49
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}